Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Cosmos Labs history
Cosmos Labs company history timeline
By the beginning of 1995, the company had 30 drugs in production, with applications filed for the introduction of 14 additional drugs.
The addition of a second manufacturing plant in Wilson, North Carolina, in December 2000--a facility that was more than twice the size of the Laurelton plant--had provided a substantial increase in Eon's production capacity.
Substantial debt had been incurred by Hexal's buyout of J.H. Whitney's interest in 2000, prompting management to file for an initial public offering (IPO) of stock to take advantage of Eon's vibrant growth.
Sales leaped upwards as a result, reaching $165 million in 2001, or more than twice the total generated two years earlier.
2002: Eon completes its initial public offering of stock, with Hexal remaining a majority owner.
Attention from investors intensified in late 2003 when Eon broke with tradition and gave onlookers a glimpse at what the future held for the company.
By 2004, three of every four drugs produced by the company entered the market on the first day, or shortly thereafter, the patents for the branded drug expired.
2004: Eon begins shipping a generic version of Wellbutrin.
Rate how well Cosmos Labs lives up to its initial vision.
Cosmos Labs jobs
Do you work at Cosmos Labs?
Is Cosmos Labs' vision a big part of strategic planning?
Zippia gives an in-depth look into the details of Cosmos Labs, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Cosmos Labs. The employee data is based on information from people who have self-reported their past or current employments at Cosmos Labs. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Cosmos Labs. The data presented on this page does not represent the view of Cosmos Labs and its employees or that of Zippia.
Cosmos Labs may also be known as or be related to Cosmos Labs, Cosmos Labs Inc and Cosmos Labs, Inc.